Irinotecan Supplier-Buyer Network — Trade Flow Analysis

Name: Irinotecan Supplier-Buyer Trade Network Dataset — 164+ Indian Exporters, 21+ Importers, 111+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Irinotecan supplier network, Irinotecan buyers, pharmaceutical export India, Irinotecan trade data

TransData Nexus

Irinotecan

India Pharmaceutical Trade Intelligence

$41.1M164 Suppliers111 CountriesHS 30049049

ExportsIndia → GERMANY19.7%India → POLAND10.7%

ImportsAUSTRALIA → India$78.4M FRANCE → India$17.9M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: FRESENIUS KABI

Who Supplies Irinotecan? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Irinotecan exporter from India, with a market share of 13.4% and a total export value of $5.5M across 670 shipments. Their average shipment value of $8.2K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 88.7% of this supplier's tracked business. Top customers include:

• FRESENIUS KABI DEUTSCHLAND GMBH — $4.9M across 594 shipments (88.7% of this supplier's total exports)

• FRESENIUS KABI THAIL — $169.6K across 21 shipments (3.1% of this supplier's total exports)

• FRESENIUS KABI CHILE — $158.8K across 19 shipments (2.9% of this supplier's total exports)

• FRESENIUS KABI COLOM — $152.0K across 19 shipments (2.8% of this supplier's total exports)

• ZUELLIG PHARMA VIETN — $142.2K across 17 shipments (2.6% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (670 shipments) at a per-shipment value of $8.2K, indicating a broad distribution network with many smaller, regular orders.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Irinotecan exporter from India, with a market share of 10.3% and a total export value of $4.2M across 88 shipments. Their average shipment value of $48.1K is above the market average of $14.2K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EUGIA PHARMA INC — $2.0M across 42 shipments (47.2% of this supplier's total exports)

• EUGIA US LLC — $1.1M across 23 shipments (26.2% of this supplier's total exports)

• EUGIA US LLC — $528.8K across 11 shipments (12.5% of this supplier's total exports)

• EUGIA PHARMA (MALTA) — $391.0K across 8 shipments (9.2% of this supplier's total exports)

• EUGIA PHARMA INC — $204.1K across 4 shipments (4.8% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $48.1K is 240% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.

3INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the third-largest Irinotecan exporter from India, with a market share of 9.1% and a total export value of $3.7M across 1.1K shipments. Their average shipment value of $3.4K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ALLOGA FRANCE — $1.0M across 300 shipments (27.3% of this supplier's total exports)

• TO THE ORDER — $917.5K across 269 shipments (24.5% of this supplier's total exports)

• ACCORD HEALTHCARE C/O QESTMED — $656.8K across 193 shipments (17.5% of this supplier's total exports)

• ACCORD HEALTHCARE POLSKA SP Z O O — $587.7K across 172 shipments (15.7% of this supplier's total exports)

• ACCORD HEALTHCARE POLSKA SP Z O O — $563.5K across 165 shipments (15.0% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (1.1K shipments) at a per-shipment value of $3.4K, indicating a broad distribution network with many smaller, regular orders.

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Irinotecan exporter from India, with a market share of 5.6% and a total export value of $2.3M across 92 shipments. Their average shipment value of $25.2K is above the market average of $14.2K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 83.1% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $1.9M across 76 shipments (83.1% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $149.4K across 6 shipments (6.4% of this supplier's total exports)

• M/S. SUN PHARMACEUTI — $135.4K across 5 shipments (5.8% of this supplier's total exports)

• SUN PHARMACEUTICALS — $53.9K across 2 shipments (2.3% of this supplier's total exports)

• MSSUN PHARMACEUTICAL — $52.6K across 2 shipments (2.3% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $25.2K is 78% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.

5VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the fifth-largest Irinotecan exporter from India, with a market share of 1.0% and a total export value of $413.5K across 110 shipments. Their average shipment value of $3.8K is below the market average of $14.2K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• C M C L — $153.3K across 41 shipments (37.1% of this supplier's total exports)

• U S B — $69.1K across 18 shipments (16.7% of this supplier's total exports)

• PT M L — $66.4K across 18 shipments (16.1% of this supplier's total exports)

• C M C L COSMA MEDICA — $63.6K across 17 shipments (15.4% of this supplier's total exports)

• M.E.L.S.B — $61.1K across 16 shipments (14.8% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (110 shipments) at a per-shipment value of $3.8K, indicating a broad distribution network with many smaller, regular orders.

6ACCURE LABS PRIVATE LIMITED

ACCURE LABS PRIVATE LIMITED is the fifth-largest Irinotecan exporter from India, with a market share of 0.9% and a total export value of $352.4K across 20 shipments. Their average shipment value of $17.6K is above the market average of $14.2K, suggesting premium or bulk contract pricing.

ACCURE LABS PRIVATE LIMITED serves 1 named buyer in our database. PHARMACIE CENTRALE DES HOPITAUX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• PHARMACIE CENTRALE DES HOPITAUX — $352.4K across 20 shipments (100.0% of this supplier's total exports)

Key Insight: ACCURE LABS PRIVATE LIMITED's per-shipment value of $17.6K is 24% above the market average of $14.2K, consistent with large-order contracts or value-added formulations.

1Germany

Germany ranks as the first-largest destination for Irinotecan imports from India, with a total trade value of $8.1M across 452 shipments — representing a 19.7% share of all Irinotecan exports. The average shipment value of $17.9K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Irinotecan importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 99.6% ($8.1M) of this market's total imports.

• FRESENIUS KABI DEUTSCHLAND GMBH — $8.1M (99.6% of Germany's total)

Key Insight: Germany's per-shipment average of $17.9K (27% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Irinotecan imports from India.

Primary Market

Secondary Market

2Poland

Poland ranks as the second-largest destination for Irinotecan imports from India, with a total trade value of $4.4M across 131 shipments — representing a 10.7% share of all Irinotecan exports. The average shipment value of $33.5K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Irinotecan importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest buyer, accounting for 33.4% ($1.5M) of this market's total imports.

• ACCORD HEALTHCARE POLSKA SP. Z.O.O. — $1.5M (33.4% of Poland's total)

• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $1.3M (28.6% of Poland's total)

• ACCORD HEALTHCARE POLSKA SP Z O O — $563.5K (12.8% of Poland's total)

Key Insight: Poland's per-shipment average of $33.5K (136% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Poland is a key market for Irinotecan imports from India.

Primary Market

Secondary Market

3Netherlands

Netherlands ranks as the third-largest destination for Irinotecan imports from India, with a total trade value of $3.4M across 116 shipments — representing a 8.3% share of all Irinotecan exports. The average shipment value of $29.6K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Irinotecan importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 71.1% ($2.4M) of this market's total imports.

• ALLOGA FRANCE — $2.4M (71.1% of Netherlands's total)

• BROCACEF NL : HUB — $744.9K (21.7% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $29.6K (109% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Irinotecan imports from India.

Primary Market

Secondary Market

4Belgium

Belgium ranks as the fourth-largest destination for Irinotecan imports from India, with a total trade value of $3.0M across 78 shipments — representing a 7.3% share of all Irinotecan exports. The average shipment value of $38.4K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Irinotecan importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 92.4% ($2.8M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $2.8M (92.4% of Belgium's total)

Key Insight: Belgium's per-shipment average of $38.4K (171% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Irinotecan imports from India.

Primary Market

Secondary Market

5Canada

Canada ranks as the fifth-largest destination for Irinotecan imports from India, with a total trade value of $2.9M across 21 shipments — representing a 7.1% share of all Irinotecan exports. The average shipment value of $138.8K is above the global average of $14.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Irinotecan importers in Canada: EUGIA PHARMA INC is the largest buyer, accounting for 68.6% ($2.0M) of this market's total imports.

• EUGIA PHARMA INC — $2.0M (68.6% of Canada's total)

• ACCORD HEALTHCARE INC — $430.7K (14.8% of Canada's total)

Key Insight: Canada's per-shipment average of $138.8K (880% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Irinotecan imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Irinotecan.
2.Flow Mapping: 164 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,905 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 111 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,905 Verified Shipments

164 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Irinotecan

Irinotecan

Who Supplies Irinotecan? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Irinotecan — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Irinotecan? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Irinotecan Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1FRESENIUS KABI ONCOLOGY LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3INTAS PHARMACEUTICALS LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

5VENUS REMEDIES LIMITED

6ACCURE LABS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Irinotecan Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Irinotecan Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Germany

2Poland

3Netherlands

4Belgium

5Canada

People Also Ask — Irinotecan Supplier & Trade Network

Irinotecan Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology